News
TCBP
1.310
-8.39%
-0.120
Weekly Report: what happened at TCBP last week (0318-0322)?
Weekly Report · 3d ago
TT BioPharm Has Received A Decision To Grant European Patent Number EP3283620 Titled "Modified Gamma Delta Cells And Uses Thereof (For The Treatment Of Cancer Or Infectious Diseases In A Human)"
Benzinga · 03/21 19:32
CGC, ATOS and MODG are among pre market gainers
On the Move CGC, ATOS and MODG are among pre market gainers. Treasure Global (TGL) and Getty Images Holdings (GETY) gain 47% and 28% respectively. Canopy Growth (CGC) and Nature's Miracle Holding (NMHI) also climb.
Seeking Alpha · 03/20 12:17
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Ontrak (NASDAQ:OTRK) shares rose 173.2% to $0.52 during Tuesday's pre-market session. Fusion Pharmaceuticals and Enveric Biosciences moved upwards by 97.46% and 39.09% respectively. Losers include Seelos Therapeutics and Acurx Pharmaceuticals.
Benzinga · 03/19 13:05
Why Science Applications International Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Science Applications International Corporation shares dipped 10.7% to $127.29 on Monday. The company reported financial fourth-quarter EPS below estimates. Canoo Inc. Shares surged 95% after the US Department of Commerce approved its Oklahoma City facility as a Foreign Trade Zone.
Benzinga · 03/18 18:37
Canopy Growth, Outlook Therapeutics, Immuneering among healthcare movers
Healthcare On the Move: Canopy Growth, Outlook Therapeutics, Immuneering among healthcare movers. S&P 500 Health Care Sector +0.1% to 1692.1. Pharmaceuticals, Biotechnology & Life Science contributes 58% to index.
Seeking Alpha · 03/18 14:00
12 Health Care Stocks Moving In Monday's Pre-Market Session
Applied DNA Sciences (APDN) stock moved upwards by 33.1% to $0.49 during Monday's pre-market session. XTL Biopharmaceuticals (XTLB) shares increased by 19.31%. 2seventy bio (TSVT) shares rose 17.7%. Titan Pharma (TTNP) shares declined by 18.2% during the session.
Benzinga · 03/18 13:05
Weekly Report: what happened at TCBP last week (0311-0315)?
Weekly Report · 03/18 10:32
12 Health Care Stocks Moving In Thursday's Intraday Session
Psyence Biomedical (NASDAQ:PBM) shares rose 52.9% to $1.59 during Thursday's regular session. Aptorum Gr stock moved upwards by 43.65% to $6.22. Mira Pharmaceuticals stock rose by 17.27%.
Benzinga · 03/14 17:31
Renalytix, CareMax, TC BioPharm among healthcare movers
Healthcare On the Move: Renalytix, CareMax, TC BioPharm among healthcare movers. S&P 500 Health Care Sector -0.08% to 1701.07. Pharmaceuticals, Biotechnology & Life Science contributes 58% to index.
Seeking Alpha · 03/12 14:00
Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Mesoblast shares jumped 13.4% to $2.4399 on Monday. The company announced FDA support of an accelerated approval pathway for end-stage heart failure patients. Kidpik Corp. Shares gained 238% in today's mid-day session.
Benzinga · 03/11 17:41
12 Health Care Stocks Moving In Monday's Intraday Session
Regencell Bioscience (NASDAQ:RGC) shares rose 130.9% to $10.39 during Monday's regular session. The company's market cap stands at $135.2 million. TC BioPharm (Holdings) shares increased by 76.41% during the session. Mesoblast stock rose 22.79% and Graphite Bio stock moved upwards.
Benzinga · 03/11 17:31
BUZZ-U.S. STOCKS ON THE MOVE-Viatris, National Fuel Gas, Moderna
Wall Street's main stock indexes dipped on Monday. The Dow Jones Industrial Average was down 0.33% and the S&P 500 was also down. China ADRs rise mirroring gains in domestic shares on inflation rebound. Viatris, National Fuel Gas, Moderna are among the top U.S. Stocks on the move.
Reuters · 03/11 15:55
BUZZ-U.S. STOCKS ON THE MOVE-Hyatt, Fortrea, China ADRs
Dow Jones Industrial Average down 0.48% on Monday. China ADRs rise mirroring gains in domestic shares on inflation rebound. Wall Street's main stock indexes dip as investors await key inflation data this week. Hyatt, Fortrea, China ADR's rise in value.
Reuters · 03/11 14:55
Lexicon Pharmaceuticals, Mesoblast, Ventyx Biosciences among healthcare movers
Seeking Alpha · 03/11 14:00
US Stocks Down; Dow Falls 100 Points
U.S. Stocks traded lower on Monday, with the Dow Jones index dipping around 100 points. The Dow traded down 0.27% to 38,618.51 while the NASDAQ fell 0.16%. Kidpik Corp. Shares shot up 254% to $9.57 after the company announced a reverse stock split. Eltek Ltd. Shares dropped 22% after posting downbeat quarterly earnings.
Benzinga · 03/11 13:47
ETRN, CRDF and KC are among pre market gainers
On the Move ETRN, CRDF and KC are among pre market gainers. Kidpik (PIK) +281%. L.S. Starrett (SCX) Enters into a Merger Agreement with MiddleGround Capital to become a private company.
Seeking Alpha · 03/11 13:30
12 Health Care Stocks Moving In Monday's Pre-Market Session
TC BioPharm (Holdings) shares increased by 74.5% to $1.85 during Monday's pre-market session. Dyadic International stock rose 21.73% and Mesoblast shares rose 19.53%. Ainos (NASDAQ:AIMD) shares fell 15.6% and Nexalin Technology shares decreased by 11.64%.
Benzinga · 03/11 13:05
Why Fangdd Network Group Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
Shares of Fangdd Network Group Ltd. Rose sharply in today’s pre-market trading. The company announced its 2024 strategic layout with plans to enter the real estate stock asset services sector. Kidpik Corp. Shares rose 311% to $11.10 in pre- market trading.
Benzinga · 03/11 12:08
Weekly Report: what happened at TCBP last week (0304-0308)?
Weekly Report · 03/11 10:30
More
Webull provides a variety of real-time TCBP stock news. You can receive the latest news about TC BioPharm (Holdings) Ltd through multiple platforms. This information may help you make smarter investment decisions.
About TCBP
TC BioPharm Limited is a clinical-stage biopharmaceutical company. The Company is engaged in developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma-delta T cell therapies for the treatment of infectious disease. The Company's platform technology allows the Company to design specific therapies to treat a range of cancers and infectious diseases with off-the-shelf allogeneic gamma-delta T cell (GDT) products. The Company’s pipeline includes OmnImmune and CAR-T programs. OmnImmune is an unmodified allogeneic gamma-delta T cell product being used for the treatment of acute myeloid leukemia (AML). The Company has completed a Phase II clinical trial. Its CAR-T programs include in-house and partner programs at the pre-clinical-stage focused on developing CAR modified allogeneic gamma delta T-cell products targeting solid and hematological indications.